Cell therapy a ‘meaningful’ advance for post-transplant lymphoproliferative disease

· by · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. ·


https://www.healio.com/news/hematology-oncology/20220429/cell-therapy-a-meaningful-advance-for-posttransplant-lymphoproliferative-disease

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.